NCT07173556 2025-09-15A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast CancerQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting96 enrolled
NCT07083505 2025-07-24A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT06941142 2025-04-23A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 Not yet recruiting382 enrolled
NCT06354114 2024-04-09A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011CSPC Ouyi Pharmaceutical Co., Ltd.Phase 2 Not yet recruiting80 enrolled